Upregulation of CD8+ regulatory T cells following liver-directed AAV gene therapy.

[1]  C. D. Gaddie,et al.  Induction of antigen-specific tolerance by hepatic AAV immunotherapy regardless of T cell epitope usage or mouse strain background , 2022, Molecular therapy. Methods & clinical development.

[2]  Anaïs Levescot,et al.  Regulatory CD8+ T cells suppress disease , 2022, Science.

[3]  Shruti Mishra,et al.  CD8+ Regulatory T Cell – A Mystery to Be Revealed , 2021, Frontiers in Immunology.

[4]  J. Bulcha,et al.  Viral vector platforms within the gene therapy landscape , 2021, Signal Transduction and Targeted Therapy.

[5]  V. Arruda,et al.  Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A , 2020, Frontiers in Immunology.

[6]  R. Samulski,et al.  Engineering adeno-associated virus vectors for gene therapy , 2020, Nature Reviews Genetics.

[7]  M. Wallet,et al.  Type I IFN Sensing by cDCs and CD4+ T Cell Help Are Both Requisite for Cross-Priming of AAV Capsid-Specific CD8+ T Cells. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  Mark M. Davis,et al.  Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis , 2019, Nature.

[9]  S. Antonia,et al.  The NKG2A immune checkpoint — a new direction in cancer immunotherapy , 2019, Nature Reviews Clinical Oncology.

[10]  G. Gao,et al.  Adeno-associated virus vector as a platform for gene therapy delivery , 2019, Nature Reviews Drug Discovery.

[11]  M. Welters,et al.  NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines , 2018, Cell.

[12]  J. Serody,et al.  Bim regulates the survival and suppressive capability of CD8+ FOXP3+ regulatory T cells during murine GVHD. , 2018, Blood.

[13]  S. Crosson,et al.  Helper-free Production of Laboratory Grade AAV and Purification by Iodixanol Density Gradient Centrifugation , 2018, Molecular therapy. Methods & clinical development.

[14]  G. Ronzitti,et al.  Emerging Issues in AAV-Mediated In Vivo Gene Therapy , 2017, Molecular therapy. Methods & clinical development.

[15]  F. Mingozzi,et al.  Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial , 2017, Human gene therapy.

[16]  D. Markusic,et al.  Gene Therapy-Induced Antigen-Specific Tregs Inhibit Neuro-inflammation and Reverse Disease in a Mouse Model of Multiple Sclerosis , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  N. Ferry,et al.  Alloantigen gene transfer to hepatocytes promotes tolerance to pancreatic islet graft by inducing CD8+ regulatory T cells. , 2017, Journal of hepatology.

[18]  Dacan Chen,et al.  CD8+CD122+ T-Cells: A Newly Emerging Regulator with Central Memory Cell Phenotypes , 2015, Front. Immunol..

[19]  Christopher M. Jackson,et al.  Lymphocyte Activation Gene 3 (LAG-3) Modulates the Ability of CD4 T-cells to Be Suppressed In Vivo , 2014, PloS one.

[20]  K. Karimi,et al.  Hepatocytes induce Foxp3+ regulatory T cells by Notch signaling , 2014, Journal of leukocyte biology.

[21]  X. Li,et al.  A naturally occurring CD8+CD122+ T-cell subset as a memory-like Treg family , 2014, Cellular and Molecular Immunology.

[22]  M. R. Delgado Alvira,et al.  Absolute determination of single-stranded and self-complementary adeno-associated viral vector genome titers by droplet digital PCR. , 2014, Human gene therapy methods.

[23]  X. Li,et al.  Natural CD8+CD122+ T Cells Are More Potent in Suppression of Allograft Rejection Than CD4+CD25+ Regulatory T Cells , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  R. Samulski,et al.  Adeno-associated virus capsid antigen presentation is dependent on endosomal escape. , 2013, The Journal of clinical investigation.

[25]  Alexandra C. Chadwick,et al.  CD8+ Foxp3+ Regulatory T Cells Are Induced during Graft-versus-Host Disease and Mitigate Disease Severity , 2012, The Journal of Immunology.

[26]  G. Hill,et al.  Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation. , 2012, Blood.

[27]  Nicolas Produit,et al.  Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice. , 2012, Journal of autoimmunity.

[28]  Pratima Chowdary,et al.  Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. , 2011, The New England journal of medicine.

[29]  A. Nienhuis,et al.  Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  T. Okazaki,et al.  PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice , 2011, The Journal of experimental medicine.

[31]  D. Roopenian,et al.  CD8+ T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice , 2011, Proceedings of the National Academy of Sciences.

[32]  Y. Okuno,et al.  CD8+CD122+ Regulatory T Cells (Tregs) and CD4+ Tregs Cooperatively Prevent and Cure CD4+ Cell-Induced Colitis , 2011, The Journal of Immunology.

[33]  H. Dai,et al.  Cutting Edge: Programmed Death-1 Defines CD8+CD122+ T Cells as Regulatory versus Memory T Cells , 2010, The Journal of Immunology.

[34]  James M. Wilson,et al.  Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver , 2009, Hepatology.

[35]  R. Herzog,et al.  Role of regulatory T cells in tolerance to coagulation factors , 2009, Journal of thrombosis and haemostasis : JTH.

[36]  J. Orange,et al.  Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors. , 2009, The Journal of clinical investigation.

[37]  R. Herzog,et al.  Improved induction of immune tolerance to factor IX by hepatic AAV-8 gene transfer. , 2009, Human gene therapy.

[38]  R. Herzog,et al.  Hepatic gene transfer as a means of tolerance induction to transgene products. , 2009, Current gene therapy.

[39]  R. Herzog,et al.  Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy. , 2009, Blood.

[40]  B. Dale,et al.  Regulatory T Cells Inhibit Dendritic Cells by Lymphocyte Activation Gene-3 Engagement of MHC Class II1 , 2008, The Journal of Immunology.

[41]  K. Isobe,et al.  Essential Role of CD8+CD122+ Regulatory T Cells in the Recovery from Experimental Autoimmune Encephalomyelitis1 , 2008, The Journal of Immunology.

[42]  D. Getnet,et al.  LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems. , 2007, The Journal of clinical investigation.

[43]  J. F. Wright,et al.  Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver. , 2007, Blood.

[44]  R. Herzog,et al.  Emerging role of regulatory T cells in gene transfer. , 2007, Current gene therapy.

[45]  R. Herzog,et al.  Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer. , 2007, Blood.

[46]  Marcela V Maus,et al.  CD8+ T-cell responses to adeno-associated virus capsid in humans , 2007, Nature Medicine.

[47]  H. Wiendl,et al.  Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients , 2007, Clinical and experimental immunology.

[48]  J. Gray,et al.  Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates. , 2007, Blood.

[49]  R. Herzog,et al.  Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Rasko,et al.  Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response , 2006, Nature Medicine.

[51]  K. Isobe,et al.  Cutting Edge: CD8+CD122+ Regulatory T Cells Produce IL-10 to Suppress IFN-γ Production and Proliferation of CD8+ T Cells1 , 2005, The Journal of Immunology.

[52]  R. Herzog,et al.  Tolerance induction by viral in vivo gene transfer. , 2005, Clinical medicine & research.

[53]  B. Bisikirska,et al.  TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. , 2005, The Journal of clinical investigation.

[54]  C. Bécourt,et al.  Peripheral CD8+CD25+ T Lymphocytes from MHC Class II-Deficient Mice Exhibit Regulatory Activity1 , 2005, The Journal of Immunology.

[55]  Y. Kawamoto,et al.  Essential Roles of CD8+CD122+ Regulatory T Cells in the Maintenance of T Cell Homeostasis , 2004, The Journal of experimental medicine.

[56]  C. Drake,et al.  Role of LAG-3 in regulatory T cells. , 2004, Immunity.

[57]  R. Herzog,et al.  Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer. , 2004, Blood.

[58]  Yuqin Wang,et al.  Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. , 2003, The Journal of clinical investigation.

[59]  C. Slaughter,et al.  Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. , 2002, Blood.

[60]  R. Herzog,et al.  Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy. , 2002, Blood.

[61]  B. Byrne,et al.  Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield , 1999, Gene Therapy.

[62]  T. Mak,et al.  Normal thymic selection, superantigen-induced deletion and Fas-mediated apoptosis of T cells in IL-2 receptor beta chain-deficient mice. , 1997, International immunology.

[63]  S. Roman-Roman,et al.  LAG-3, a novel lymphocyte activation gene closely related to CD4 , 1990, The Journal of experimental medicine.

[64]  R. Gershon,et al.  Cell interactions in the induction of tolerance: the role of thymic lymphocytes. , 1970, Immunology.

[65]  James M. Wilson,et al.  Assessment of Humoral, Innate, and T-Cell Immune Responses to Adeno-Associated Virus Vectors. , 2018, Human gene therapy methods.

[66]  Lili Wang,et al.  AAV8 induces tolerance in murine muscle as a result of poor APC transduction, T cell exhaustion, and minimal MHCI upregulation on target cells. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.